| Related Information: |
| European Union: Nitrosamines: EMA aligns recommendations for sartans with those ... 上載於 2020-11-14 |
| The United States: FDA updates and press announcements on angiotensin II recepto... 上載於 2019-11-14 |
| The United States: Torrent Pharmaceuticals Limited expands voluntary nationwide ... 上載於 2019-09-21 |
| United States: Macleods Pharmaceutical Limited Issues Voluntary Nationwide Consu... 上載於 2019-06-27 |
| The United States: Teva Pharmaceuticals USA, Inc. expands voluntary nationwide r... 上載於 2019-06-12 |
| The United States: Sciegen Pharmaceuticals, Inc. issues voluntary nationwide rec... 上載於 2019-06-12 |
| Singapore: Recall of three brands of losartan products found to contain N-Nitros... 上載於 2019-05-09 |
| The United States: Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Rec... 上載於 2019-05-04 |
| The United States: Teva Pharmaceuticals USA, Inc. issues voluntary nationwide re... 上載於 2019-04-29 |
| The United States: Legacy Pharmaceutical Packaging, LLC expands voluntary nation... 上載於 2019-04-25 |
| Canada: Auro Pharma Inc. voluntarily recalls one lot of Auro-Irbesartan HCT tabl... 上載於 2019-04-23 |
| The United States: Updated: Torrent Pharmaceuticals Limited expands voluntary na... 上載於 2019-04-23 |
| Singapore: HSA recalls three brands of losartan medicines from Hetero Labs Ltd (... 上載於 2019-03-29 |
| 台灣：回收緩壓膜衣錠 50 毫克 Losacar 50 Tablets 上載於 2019-03-23 |
| 台灣：回收壓寧悅膜衣錠 50/12.5 毫克 Hysartan F.C. Tablets 50/12.5 mg 上載於 2019-03-23 |
| The United Kingdom: Class 2 Medicines recall: Accord Healthcare Limited - Losart... 上載於 2019-03-22 |
| The United States: Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationw... 上載於 2019-03-16 |
| Canada: Pro Doc Limitée voluntarily recalls two lots of irbesartan drugs because... 上載於 2019-03-15 |
| Canada: Multiple losartan-containing drugs voluntarily recalled because of poten... 上載於 2019-03-11 |
| The United States: American Health Packaging issues voluntary nationwide recall ... 上載於 2019-03-08 |
| 台灣：Sartan類高血壓又發現新的不純物NMBA，食藥署啟動預防性下架機制 上載於 2019-03-04 |
| The United States: Updated: Torrent Pharmaceuticals Limited issues voluntary nat... 上載於 2019-03-02 |
| The United States: Aurobindo Pharma USA, Inc. initiates a voluntary nationwide c... 上載於 2019-03-02 |
| The United States: Camber Pharmaceuticals, Inc. issues voluntary nationwide reca... 上載於 2019-03-01 |
| 台灣：食藥署說明沙坦類（sartan）藥品中「N-亞硝基二甲胺（NDMA）」及「N-亞硝基二乙胺（NDEA）」之處理現況 上載於 2019-02-28 |
| The United States: Macleods Pharmaceuticals Limited issues voluntary nationwide ... 上載於 2019-02-26 |
| Australia: ‘Sartan’ blood pressure medicines: TGA investigation - potential cont... 上載於 2019-02-26 |
| 台灣：有關健喬信元醫藥生技股份有限公司「衛欣保膜衣錠80毫克」、「衛欣保膜衣錠160毫克」及景德製藥股份有限公司「"景德"定壓寧膠囊80毫克」回收事件說明 上載於 2019-02-16 |
| The United Kingdom: Class 2 Medicines Recall: Actavis Group PTC EHF - Irbesartan... 上載於 2019-02-14 |
| European Medicines Agency: Press release: Sartan medicines: companies to review ... 上載於 2019-02-02 |
| The United Kingdom: Class 2 Medicines Recall: Macleods Pharma UK Limited - Irbes... 上載於 2019-01-25 |
| The United States: Torrent Pharmaceuticals Limited issues voluntary nationwide r... 上載於 2019-01-23 |
| 台灣：食藥署說明目前完成清查沙坦類（Sartan）藥品中「N-亞硝基二甲胺（NDMA）」及「N-亞硝基二乙胺（NDEA）」之檢驗結果 上載於 2019-01-21 |
| The United States: Prinston Pharmaceutical Inc. issues voluntary nationwide reca... 上載於 2019-01-19 |
| The United Kingdom: Class 2 Medicines Recall: Actavis Group PTC EHF - recall of ... 上載於 2019-01-04 |
| The United States: Aurobindo Pharma USA, Inc. initiates voluntary nationwide con... 上載於 2019-01-02 |
| 台灣: 有關壽元化學工業股份有限公司回收「脈莎平膜衣錠 50 毫克」事件說明 上載於 2018-12-31 |
| 台灣: 回收脈莎平膜衣錠 50 毫克 Cosar F.C. Tablets 50 mg 上載於 2018-12-28 |
| Canada: Health Canada releases test results of certain sartan drugs (English Onl... 上載於 2018-12-21 |
| The United States: Torrent Pharmaceuticals Limited issues voluntary nationwide r... 上載於 2018-12-21 |
| Australia: Recall for IRBESARTAN／HCT SANDOZ 300／12.5 and IRBESARTAN／HCT SANDOZ 3... 上載於 2018-12-19 |
| Australia: Recall - potential contamination: APO-Valsartan (valsartan) tablets (... 上載於 2018-12-19 |
| The United States: FDA warns API manufacturer involved in valsartan recall, prov... 上載於 2018-12-12 |
| The United States: Mylan expands its voluntary nationwide recall of Valsartan Ta... 上載於 2018-12-05 |
| The United Kingdom: Class 2 Medicines Recall: Teva UK Limited and Mylan - recall... 上載於 2018-12-01 |
| Canada: Information Update - Mylan-Valsartan medications voluntarily recalled as... 上載於 2018-11-30 |
| The United States: Teva Pharmaceuticals USA issues voluntary nationwide recall o... 上載於 2018-11-28 |
| Australia: Recall - potential contamination: Dilart and Dilart HCT (valsartan) (... 上載於 2018-11-23 |
| 台灣：回收洛沙坦山德士膜衣錠50/12.5毫克 Losartan Sandoz Comp Film Coated Tablet 50/12.5 mg 上載於 2018-11-23 |
| The United States: Mylan initiates voluntary nationwide recall of 15 lots of Val... 上載於 2018-11-22 |
| 台灣：有關健亞生物科技股份有限公司回收「壓穩膜衣錠80毫克」及「壓穩膜衣錠160毫克」事件說明 上載於 2018-11-21 |
| 台灣：回收壓穩膜衣錠80毫克 Prevan Film-Coated Tablets 80mg 上載於 2018-11-20 |
| European Union: Valsartan from Mylan laboratories in India can no longer be used... 上載於 2018-11-20 |
| 台灣：回收壓穩膜衣錠160毫克 Prevan Film-coated Tablets 160mg 上載於 2018-11-20 |
| The United States: Sandoz Inc. issues voluntary nationwide recall of one lot of ... 上載於 2018-11-10 |
| 台灣：食藥署調查使用印度Aurobindo Pharma Limited公司Irbesartan原料藥之異常事件說明，及回收「平壓妥膜衣錠300毫克Bestan... 上載於 2018-11-03 |
| The United States: ScieGen Pharmaceuticals, Inc. issues voluntary nationwide rec... 上載於 2018-10-31 |
| The United States: Aurobindo Pharma Limited issues voluntary recall of irbesarta... 上載於 2018-10-30 |
| The United States: FDA updates recalled valsartan-containing product information... 上載於 2018-10-25 |
| European Union: EU authorities take further action in ongoing review of sartans:... 上載於 2018-10-16 |
| The United States: FDA posts laboratory analysis of NDMA levels in recalled vals... 上載於 2018-10-06 |
| Canada: Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant w... 上載於 2018-10-03 |
| The United States: FDA places Zhejiang Huahai Pharmaceuticals on import alert (E... 上載於 2018-10-02 |
| European Union: EU inspection finds Zhejiang Huahai site non-compliant for manuf... 上載於 2018-09-29 |
| European Union: Valsartan: review of impurities extended to other sartan medicin... 上載於 2018-09-22 |
| European Union: Update on review of valsartan medicines. Risk from NDMA remains ... 上載於 2018-09-14 |
| The United States: FDA provides update on its ongoing investigation into valsart... 上載於 2018-09-14 |
| Canada: Health Canada advises of a second impurity linked to recalled valsartan ... 上載於 2018-09-14 |
| Canada: Health Canada updates Canadians on estimates of health risks for recalle... 上載於 2018-09-11 |
| The United States: Updated: Torrent Pharmaceuticals Limited issues voluntary nat... 上載於 2018-09-01 |
| 美國：更新：Torrent Pharmaceuticals Limited自願全國性回收Valsartan/Amlodipine/HCTZ Tablets、Va... 上載於 2018-08-22 |
| 歐洲聯盟：有關含有浙江天宇纈沙坦藥物的資料更新。因含有NDMA該公司不再獲授權生產用於歐洲聯盟藥品的纈沙坦原料藥 上載於 2018-08-21 |
| 加拿大：Teva Canada擴大回收額外批次的纈沙坦藥物以作為預防措施 上載於 2018-08-20 |
| 美國：Torrent Pharmaceuticals Limited自願全國性回收Valsartan/Amlodipine/HCTZ Tablets 上載於 2018-08-20 |
| 歐洲聯盟：審查纈沙坦藥物檢測到NDMA的更新。歐洲藥物監管局正審查另一家公司(浙江天宇)生產的纈沙坦。 上載於 2018-08-11 |
| 美國：Camber Pharmaceuticals, Inc.因在原料藥中檢測到微量N-nitrosodimethylamine (NDMA)雜質自願全國性回收... 上載於 2018-08-10 |
| 美國：食物及藥物管理局有關回收纈沙坦藥物的更新 上載於 2018-08-08 |
| 台灣：輸入valsartan原料藥已完成清查，未有新增其他市售藥品受影響 上載於 2018-08-06 |
| 歐洲聯盟：回收纈沙坦藥物的審查更新。初步評估可能給病人帶來的風險。 上載於 2018-08-03 |
| 台灣：食藥署全面調查valsartan原料藥異常事件說明 上載於 2018-08-03 |
| Updates on the recall of valsartan-containing products (Letter to Healthcare Pro... 上載於 2018-08-03 |
| 美國：食物及藥物管理局更新給醫護專業人員和病人有關纈沙坦藥物回收的資訊 上載於 2018-07-19 |
| 歐洲聯盟：在原料藥檢測到雜質後審查纈沙坦藥物的更新 上載於 2018-07-18 |
| 美國：食物及藥物管理局在檢測到雜質後宣佈自願回收幾種含有纈沙坦的藥物 上載於 2018-07-14 |
| 英國：第一級藥物回收：立即採取行動 - 包括非辦公時間藥房回收(含有纈沙坦的藥物) 上載於 2018-07-11 |
| 台灣：食藥署調查使用中國大陸浙江華海製藥公司valsartan原料藥之異常事件接續說明 上載於 2018-07-10 |
| 加拿大：因受潛在致癌物污染而回收幾種含有纈沙坦的藥物 上載於 2018-07-10 |
| Recall of five valsartan-containing products (Letter to Healthcare Professionals... 上載於 2018-07-09 |
| 歐洲聯盟：歐洲藥物監管局在檢測到雜質後審查含有Zhejiang Huahai纈沙坦的藥物。一些纈沙坦藥物在歐洲聯盟市場上回收。 上載於 2018-07-06 |
| 英國：從藥房回收血壓和心臟科藥物(纈沙坦) 上載於 2018-07-06 |
| Recall of five valsartan-containing products (Letter to Healthcare Professionals... 上載於 2018-07-06 |
